COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics...
Marek Jutel, María José Torres, Oscar Palomares, et al.
Advances and highlights in biomarkers of allergic diseases
Ismail Ogulur, Yağız Pat, Ozge Ardicli, et al.
T regulatory cells from asthmatic individuals show a Th2-like phenotype
Kirstin Jansen, Oliver Wirz, Willem van de Veen, et al.
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis w...
Ioana Agache, Yang Song, Pablo Alonso-Coello, et al.
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines -- an EAACI-AR...
Ludger Klimek, Marek Jutel, Cezmi Akdis, et al.
Risk factors for severe and critically ill COVID-19 patients: a review
Ya-dong Gao, Mei Ding, Xiang Dong, et al.
Advances and Recent Developments in Asthma in 2020
Lacin Cevhertas, Ismail Ogulur, debbie maurer, et al.
Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systemat...
Ioana Agache, Yang Song, Margarita Posso, et al.
Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria- a...
Ioana Agache, Claudio Rocha, Yang Song, et al.
Role of Nuclear Factor of Activated T cells 2 (NFATc2) in allergic asthma
Marielena Jakobi, Alexander Kiefer, Hooman Mirzakhani , et al.
Clinical, radiological and laboratory characteristics and risk factors for severity a...
Jin-jin Zhang, Yi-yuan Cao, Ge Tan, et al.
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
CARMEN RIGGIONI, Pasquale Comberiati, Mattia Giovannini, et al.